Mental Health Disorder - Depression Visual representation of a mental health disorder. Man panicking and hitting his head. schizophrenia man stock videos & royalty-free footage Visual representation ...

Browse 30+ child schizophrenia stock videos and clips available to use in your projects, or start a new search to explore more stock footage and b-roll video clips. This sad unhappy male abstract clip ...

These doctors diagnose and specialize in the treatment of schizophrenia and other mental, emotional, or behavioral problems. They can prescribe medications and do “talk therapy.” They can’t ...

The retina is part of the central nervous system, and therefore a direct extension of the brain. This is why changes in the brain could potentially also be detected in our eyes. An international ...

Tools, resources, and support for living with schizophrenia.

Schizophrenia is a severe and debilitating psychiatric disorder that involves psychotic symptoms such as hallucinations and delusions, accompanied with regressive behaviour.

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

Shares in Neurocrine Bioscience took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors. The 19% after-market selloff ...

Credit: Dennis Diatel / Shutterstock. US-based pharmaceutical company Bristol Myers Squibb (BMS) has reported topline outcomes from the Phase III ARISE trial of Cobenfy as an adjunctive treatment to ...

Get Instant Summarized Text (Gist) New global guidelines for treating schizophrenia emphasize shared decision-making and individualized care, aiming to improve adherence and quality of life. They ...

Brexpiprazole was associated with a greater reduction in schizophrenia symptoms over 6 weeks in adolescents compared with placebo, with a tolerable safety profile, in a new phase 3 trial.

The proportion of schizophrenia cases linked to cannabis use disorder in Ontario nearly tripled from 2006 to 2022 amid major cannabis policy liberalization. The proportion of new schizophrenia cases ...